Publikationen

Publikationen ab 2008:

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators. N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators. N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.

SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.Cohen A, Stellbrink C, Le Heuzey JY, Faber T, Aliot E, Banik N, Kropff S, Omran H; SAFE-AF investigators. Arch Cardiovasc Dis. 2015 Feb;108(2):122-31. doi: 10.1016/j.acvd.2014.09.009. Epub 2014 Nov 6.

German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization. Krankenberg H, Tübler T, Sixt S, Fischer M, Schmiedel R, Schulte KL, Balzer JO, Kieback A, Fiehn E, Wittenberg G, Ali T, Tiefenbacher C, Jahnke T, Steinkamp HJ, Wegscheider K, Treszl A, Ingwersen M, Zeller T.J Endovasc Ther. 2014 Aug;21(4):463-71. doi: 10.1583/13-4625R.1.

PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.Lichtenberg M, Kolks O, Hailer B, Stahlhoff WF, Tiefenbacher C, Nolte-Ernsting C, Arjumand J, Wittenberg G.J Endovasc Ther. 2014 Jun;21(3):373-80. doi: 10.1583/13-4637R.1.

[Curriculum for interventional therapy for arterial diseases. Clinical competence for execution of catheter-based interventions on the arteries of the extremities, on the pelvic, visceral and renal arteries, on the extracranial arteries supplying the brain, and on dialysis shunts].Schulte KL, Amendt K, Hoffmann U, Tiefenbacher C, Weiss T, Mudra H, Hardung D, Nikol S. Vasa. 2012 Nov;41(6):463-76. doi: 10.1024/0301-15626/a000209. German. No abstract available.

[State of the art in carotid artery stenting 2012]. Tiefenbacher CP. Dtsch Med Wochenschr. 2012 Sep;137(39):1931-3. Epub 2012 Sep 19. Review. German.

[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries]. Tendera M, Aboyans V, Bartelink L, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T; Avrupa Kardiyoloji Derneği ESC Periferik Atardamar Hastaliklarinin Tani ve Tedavisi Görev Grubu; Avrupa Inme Organizasyonu (ESO) tarafindan desteklenmiştir. Turk Kardiyol Dern Ars. 2012 Mar;40 Suppl 1:5-60. Turkish. No abstract available.

Apixaban with antiplatelet therapy after acute coronary syndrome. Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators. N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.

[European guidelines on myocardial revascularization]. Perings SM, Bosch R, Eggeling T, Hennersdorf M, Graf La Rosee K, Korte T, Lauer T, Leschke M, Lewalter T, Mathey D, Mudra H, Reifert N, Rybak K, Sievert H, Tiefenbacher C. Herz. 2011 May;36(3):265-6. doi: 10.1007/s00059-011-3465-0. German. No abstract available.

[ROCKET AF]. Tiefenbacher CP. Herz. 2011 Mar;36(2):149-50. doi: 10.1007/s00059-011-3433-8. German. No abstract available.

The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions.Grube E, Chevalier B, Smits P, Džavík V, Patel TM, Mullasari AS, Wöhrle J, Stuteville M, Dorange C, Kaul U; SPIRIT V Investigators. JACC Cardiovasc Interv. 2011 Feb;4(2):168-75. doi: 10.1016/j.jcin.2010.11.006.

Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). Harnek J, Webb JG, Kuck KH, Tschope C, Vahanian A, Buller CE, James SK, Tiefenbacher CP, Stone GW. JACC Cardiovasc Interv. 2011 Jan;4(1):115-22. doi: 10.1016/j.jcin.2010.08.027.

Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease.Zankl AR, Ivandic B, Andrassy M, Volz HC, Krumsdorf U, Blessing E, Katus HA, Tiefenbacher CP. Clin Res Cardiol. 2010 Dec;99(12):787-94. doi: 10.1007/s00392-010-0184-0. Epub 2010 Jul 8.

GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP.  Liu Z, Shen J, Pu K, Katus HA, Plöger F, Tiefenbacher CP, Chen X, Braun T.Biochim Biophys Acta. 2009 Dec;1793(12):1819-27. doi: 10.1016/j.bbamcr.2009.09.012. Epub 2009 Sep 24.

Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats.  Dikow R, Wasserhess C, Zimmerer K, Kihm LP, Schaier M, Schwenger V, Hardt S, Tiefenbacher C, Katus H, Zeier M, Gross LM. Basic Res Cardiol. 2009 Sep;104(5):571-9. doi: 10.1007/s00395-009-0018-2. Epub 2009 Mar 14.

Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Sievert H, Ruygrok P, Salkeld M, Baumgartner H, Meier B, Windecker S, Juliard JM, Aubry P, Tiefenbacher C, Krumsdorf U, Vermeersch P, Ewert P, Piéchaud JF. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):368-73. doi: 10.1002/ccd.21809.

Significance of close surveillance of patients with peripheral arterial disease. Barrows RJ, Krumsdorf U, Zankl A, Katus H, Tiefenbacher CP. Angiology. 2009 Aug-Sep;60(4):462-7. doi: 10.1177/0003319708322923. Epub 2008 Sep 30.

Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). Zeller T, Tiefenbacher C, Steinkamp HJ, Langhoff R, Wittenberg G, Schlüter M, Buergelin K, Rastan A, Krumsdorf U, Sixt S, Schulte CL, Tübler T, Krankenberg H. J Endovasc Ther. 2008 Aug;15(4):390-8. doi: 10.1583/08-2461.1